Skip to main navigation
Medpace Corporate
  • Careers
  • Investors
  • Investigators
  • Study Participants
  • Blog
  • Japan Site
  • Login
  • About
    About

    Our mission is to accelerate the development of safe and effective medical therapeutics.

    • Company Overview 
    Trusted by Biotech Services & Capabilities Brochure: Trusted by Biotech Read More
    hospital executive meets with medical staff Whitepaper Winning at Your Drug Development Strategy – A Playbook for Emerging Biotechs Read More
    • Full-Service CRO
    • Trusted by Biotech
    • People. Purpose. Passion.
    • Leadership
    • Global Reach
    • Locations
    • Ethics & Compliance
  • CRO
    CRO

    Medpace helps biotechs accelerate the development of their medical therapeutics with a full breadth of services and collaborative model.

    • Services Overview 
    doctor speaking during conference Whitepaper A Collaborative Framework for Achieving Diversity, Equity, and Inclusion (DEI) in Clinical Trial Populations Read More
    Woman Testing Glucose Level With Continuous Glucose Monitor Whitepaper Benefits and Challenges of Continuous Glucose Monitoring (CGM) in Clinical Development Read More
    • Study Start-up
    • Clinical Trial Management
      • Sites & Patients
      • Patient Diversity in Clinical Trials
      • Decentralized Clinical Trials
    • Clinical Monitoring
    • Biostats & Data Management
    • Medical Affairs
    • Clinical Safety & Pharmacovigilance
    • Regulatory Affairs & Medical Writing
    • Quality Assurance
    • Technology
  • Therapeutics
    Therapeutics

    Our therapeutically-focused model gives sponsors early and ongoing insight from medical experts throughout trial design and execution, and facilitates collaboration across specialties to incorporate various medical perspectives and considerations.

    • Our Approach 
    • Request Information 
    Illustration of human body with heart and kidneys highlighted Blog [Webinar] Chronic Kidney Disease: Breaking Barriers with Cardiovascular and Renal Integration in Clinical Trials Read More
    data concept art Webinar Successful Approaches from Rare Disease and Cellular and Gene Therapy Product Approvals Read More
    • Therapeutic Depth
      • Autoimmune & Inflammation
      • Cardiovascular
      • Dermatology
      • Endocrine & Metabolic
      • Gastroenterology & Hepatology
      • Hematology & Oncology
      • Infectious Diseases & Vaccines
      • Non-Alcoholic Steatohepatitis
      • Nephrology & Renal Disease
      • Neuroscience
      • Ophthalmology
    • Crossovers
      • Rare Diseases
      • Cell & Gene Therapy
      • Radiation Therapy
      • Women’s Health
      • Pediatrics
      • Medical Device & Diagnostics
  • Labs
    Labs

    Medpace offers comprehensive and fully-integrated central and bioanalytical laboratory services that deliver efficient and streamlined execution.

    • Integrated for Efficiency 
    • Take a Tour 
    Flow Cytometry Webinar Establishing Efficacy with Flow Cytometry-Based Receptor Occupancy Assays Read More
    Liquid Biopsy in Oncology Article The Utility of Liquid Biopsy in Oncology Clinical Trials Read More
    • Central Lab
      • Capabilities
      • Biomarkers
      • Safety Testing
      • Featured Methods
      • Therapeutic Expertise
      • Biorepository Services
      • Accreditations
      • Test Directory
    • Bioanalytical Lab
      • Capabilities
      • Discovery & Development
      • Preclinical Studies
      • PK Studies
      • TK Studies
      • Biomarker Assays
      • ADA Assays
      • Neutralizing Antibody Assays
      • Bioanalytical Assays and Posters
  • Core Labs
    Core Labs

    Medpace Core Labs provide an end-to-end suite of global cardiac safety and imaging services to enhance and expedite biopharmaceutical and medical device development.

    • Request Information 
    nurse listening to heartbeat of senior man Article Expert Insights: Q&A with Dr. Satya Shreenivas, Cardiovascular Expert Read More
    Wearables in DCT Webinar Integrating Wearable Remote Biosensor Technology into Decentralized Clinical Trials Read More
    • Imaging Core Lab
      • Therapeutic Expertise
        • Oncology Imaging
        • Endocrine & Metabolic Imaging
        • NASH/NAFLD Imaging
        • Cardiovascular Imaging
        • Neurology Imaging
        • Dermatologic Imaging
        • Nuclear Imaging & Radiopharmaceuticals
        • DXA Imaging Services
      • Image Quantification Services
    • Cardiovascular & ECG Core Lab
    • Wearable Biosensor Technology
  • Phase I Unit
  • Insights
  • Contact
HomeInvestorsCorporate GovernanceBoard of DirectorsDani S. Zander, MD

Biography

Skip to content
Investor Relations
  • Overview
  • News Releases
  • Events & Presentations
  • Financials & Filings
    • SEC Filings
    • Annual Reports & Proxy
    • Quarterly Results
    • Annual Stockholders Meeting
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • Corporate Responsibility Report
  • Investor Resources
    • Information Request
    • IR Contact
    • Analyst Coverage
    • Email Alerts
  • Investor FAQs
Shareholder Tools
  • Print Page
  • RSS Feeds
  • Email Alerts
Headshot of  Dani S.  Zander, MD

Dani S. Zander, MD

Director

Dr. Zander is a Collaborative Professor in the Department of Pathology and Cell Biology at the University of South Florida Morsani College of Medicine. From 2016 to June 2025, Dr. Zander served as the MacKenzie Chair of the Department of Pathology and Laboratory Medicine at the University of Cincinnati, and Chief of Pathology and Laboratory Medicine for UC Health. She previously served as Chair of the Department of Pathology at Penn State and held other faculty and leadership positions at the University of Texas Health Science Center at Houston and the University of Florida College of Medicine.

Dr. Zander practiced as a lung pathologist and cytopathologist with research focused primarily on lung cancer and lung transplantation. She has been an editor of five pulmonary pathology and molecular pathology books, served as the elected president of four pathology societies and she is a past president of the Association of Pathology Chairs (APC), recently renamed as the Association for Academic Pathology (AAPath). She has published numerous papers, served on DOD and NIH study sections, and was elected chair of the DOD's Lung Cancer Research Program's Programmatic Panel. She has also held multiple editorial positions including that of Associate Editor of the American Journal of Pathology.

Leadership education and training, especially for academic pathologists, has been a passion for Dr. Zander throughout her career. She led the design and launch of the first Pathology Leadership Academy of the APC in 2016. Dr. Zander has also served as a mentor for faculty, residents and medical students and has been recognized with several teaching awards including the prestigious national Robbins Distinguished Educator Award given to Dr. Zander in 2025 by the American Society for Investigative Pathology.

Dr. Zander received her Bachelor of Arts degree in chemistry from New York University and her Doctor of Medicine from the University of Florida. Dr. Zander was chosen as a director because of her significant experience in pathology and laboratory medicine and her extensive experience in clinical research.

  • Member of the Nominating and Governance Committee
Medpace, Inc.
5400 Medpace Way, Cincinnati, Ohio 45227 USA
Toll-free: +1.800.730.5779
Tel: +1.513.579.9911
Social Media Links
  • Facebook
  • LinkedIn
  • YouTube
  • Vimeo
  • © 2026 Medpace Holdings, Inc., All Rights Reserved
  • Privacy Policy
  • Accessibility Statement
  • UK Modern Slavery Act
  • Terms of Use
  • Sitemap